Pneumococcal vaccination by general practitioners: an evaluation of current practice

Area of Science:

• Immunization Practices
• Public Health Surveillance

Background:

• The 23-valent pneumococcal vaccine was registered in Belgium.
• Understanding vaccine uptake and patient profiles is crucial for public health strategies.

Purpose of the Study:

• To analyze the uptake and administration patterns of the 23-valent pneumococcal vaccine in Belgium.
• To identify the characteristics and indications for vaccination among recipients.
• To assess the impact of public awareness campaigns on vaccination practices.

Main Methods:

• Retrospective analysis of vaccine administration data (1996-1997).
• Inclusion of 18,236 patients vaccinated between September and December.
• Data collection on patient demographics, vaccination indications, and co-administration of influenza vaccine.

Main Results:

• Vaccination coverage reached nearly 20% of the target population.
• Seasonal administration peaks observed from September to November (74-85%).
• 82% of recipients were over 60 years old, with chronic bronchopulmonary and cardiovascular diseases as primary indications.

Conclusions:

• Pneumococcal vaccination in Belgium shows seasonal trends and targets elderly individuals with specific comorbidities.
• Concomitant influenza vaccination is common.
• Public awareness campaigns positively influence vaccine uptake, suggesting areas for improvement in future strategies.